Retatrutide appears to be a new treatment in the fight against obesity. This revolutionary drug, belonging to a dual GLP-1 and tb-500 side effects GIP receptor agonist, demonstrates promising results in clinical trials. By boosting these receptors, Retatrutide controls cravings, {promotesinsulin secretion, and ultimately leads to significant reduct